Changes in somatostatin content in the cerebral cortex, especially in the temporal lobe, are a hallmark of Alzheimer’s disease [138] and a decrease in the number of SOM-INs was observed in temporal lobe brain samples from patients [139,140]. This evidence concerns the gene GRHL3 and early-onset autosomal dominant Alzheimer disease.